Cenduit Announces New Vice President, Global Sales and Marketing

Robert F. MacDougall joins Cenduit, LLC

Durham, North Carolina – May 26, 2009

Cenduit, LLC, a joint venture between Quintiles and Thermo Fisher Scientific, announced today the addition of Robert MacDougall as Vice President, Global Sales and Marketing to its senior management team.

Mr. MacDougall brings over 25 years of Enterprise Software, Integrated IT Solutions, Professional Services and Sales and Marketing leadership success to our team. “Robert’s successful track record of sales and marketing leadership will be instrumental in accelerating Cenduit’s aim to be the global leader in IWRS/IVRS solutions”, states Dr. Jogin Desai, Chief Executive Officer of Cenduit.

For the past decade, Robert’s focus has been on selling complex enterprise, web-based ASP software solutions into the global life/health sciences industry. Under Robert’s leadership, the PharmaReady™ electronic document and eCTD submission solution was introduced to the market in 2003 and now has global recognition with customers in 16 countries. “We are thrilled to have Robert join our winning team”, Dr. Desai continues.

Throughout Robert’s career, he has held positions in enterprise software solutions sales, technology consulting and alliance program management. During 15 years with AT&T, he held senior management positions while participating in AT&T’s Executive Leadership Development Program. Robert holds a Bachelor of Science from the University of Maryland, College Park, College of Business and Management with a major in Marketing.

About Cenduit, LLC

Cenduit is a joint venture between Quintiles and Thermo Fisher Scientific.  Cenduit’s powerful global enterprise unleashes an unprecedented level of clinical trial support by performing as the central conduit of data between the clinical development expertise of Quintiles and the clinical supply chain management expertise of Fisher Clinical Services.  

Cenduit delivers world-class Interactive Response Technology Solutions (IWRS/IVRS) which provide unique value to pharmaceutical, biotechnology, and clinical research organizations to manage the collection and dissemination of complex, decentralized patient data. Cenduit actively embraces the latest in IWRS/IVRS technology and tailors each solution to the unique needs and requirements of each client. Cenduit is a progressive, nimble, global market leader in delivering specialized pharmaceutical services.  Cenduit’s world-class domain consulting expertise, coupled with its applied technology, measurably improves patient enrollment, streamlines access to data, and reduces study timelines — with the singular goal of simplifying clinical trials, ensuring accuracy, and accelerating time-to-market.